There are approximately 123,000 cases and around 46,000 associated deaths from sepsis reported in England each year, with 70% of cases coming from the community and directly costing the NHS at least 1.5bn annually.Read full case study
We manage the process of generating polyclonal or recombinant Monoclonal antibodies and antigens and subsequent purification, titration, delivery optimisation, immobilisation and sensitivity & specificity analysis for use in whole blood, plasma and urine-based assays.
Medtechtomarket delivers rapid prototypes, proof of principle experiments and fully functional immunochemistry tests within a short time frame.
Utilising quantum dot, latex particle, colloidal gold and Europium conjugation, amplification and detection methods our technologies can detect samples by absorbance, luminescence, fluorescence intensity, time-resolved fluorescence and immunoturbidity.
Within our advanced biochemistry labs, we develop and optimise the reagents with traditional ELISA methodologies initially within 384-well or 1536-well microplates, allowing us to titre the reagents, assay linearities, precision and detection sensitivity using 1-5µl sample volume.
We combine a highly qualified and experienced team, with a seamlessly integrated Quality and Project Management System to develop medical diagnostics products at our accredited biohazardous, instrumentation and manufacturing facilities. That is why we typically deliver products in under 4 years with around 90% reduced costs.
Our team consists of Research Scientists, Product Developers, Development Scientists, Instrumentation Engineers, Mechanical Designers, Manufacturing Engineers, Clinical Researchers, Sales and Marketing Managers, Production Technicians and Logistics Professionals. We develop, manufacture and commercialise hardware, software, firmware, mechanical design, biochemical reagents, interpretation algorithms, connectivity and user interface aspects of test cartridges, analysers, QC Materials and electronic accessories.